NanoString’s GeoMX Digital Spatial Profiler was at the heart of a patent lawsuit filed by 10x Genomics. (NanoString Image) Seattle-based publicly traded biotech company NanoString Technologies said in ...
Bruker Corporation has emerged as the winner of an auction for NanoString Technologies and its spatial biology assets after the company filed for Chapter 11 bankruptcy earlier this year. The ...
NanoString Technologies, joined by three of its subsidiaries, have filed for protection from creditors under Chapter 11 of the U.S. Bankruptcy Code, blaming the $31 million jury award assessed against ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Seattle-based NanoString said ...
More than two months after filing for Chapter 11, NanoString Technologies has found a buyer in Bruker, which will acquire substantially all the bankrupt company’s assets for approximately $392.6 ...
NanoString’s GeoMX Digital Spatial Profiler was at the heart of a patent lawsuit filed by 10x Genomics. (NanoString Image) Shares of Seattle-based publicly traded biotech company NanoString ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min It's the second round of layoffs ...
NanoString Technologies Inc (NASDAQ:NSTG) shares are trading higher by 124.3% to $0.26 Friday afternoon after the company announced it secured a credit agreement with its existing lenders, consisting ...
Wednesday, 10x Genomics Inc TXG won an injunction in its patent litigation against NanoString Technologies Inc NSTG and its German subsidiary regarding CosMx Spatial Molecular Imager instruments. The ...
NanoString to Unveil New Platforms and Showcase Spatial Biology Research at 2022 Advances in Genome Biology and Technology (AGBT) General Meeting Live webcast of Spatial Multiomic Symposium on Monday, ...
FOSTER CITY, Calif.--(BUSINESS WIRE)-- Acrobat Genomics, NanoString Technologies, Inc. (NASDAQ:NSTG), and the Illumina Accelerator announced today their collaboration with Stanford Medicine to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results